Company intelligence / Profile preview

Plantopia

Ownership: Private
Development stage: Preclinical

Overview

Plantopia has developed a proprietary molecular farming platform to produce all four major casein proteins in sprouted oats. The company is moving from R&D to commercialization with plans for pilot-scale production of animal-free dairy proteins. Their approach enables cost-effective and scalable production of functional caseins that self-assemble into micelles similar to those in cow’s milk. Purity levels are 70–80% caseins with the remainder being oat protein and fibers. No clinical results as this is a food ingredient company.

Therapeutic areas: Other
Modalities: ProteinRecombinant proteinMolecular farming platform
Industry: Food & Nutrition

Partnerships

Union for Ethical Biotrade (UEBT) membership for ethical sourcing and sustainability initiatives

Beyond the preview

Go deeper on Plantopia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plantopia.

Explore the full profile